Cognoa innovates solutions for child developmental health. We build breakthrough products like Canvas Dx, the first and only FDA authorized autism diagnostic for children ages 1.5 to 6 years that uses responsible AI to empower doctors to quickly, accurately, and fairly diagnose developmental risk without bias. Our digital solutions are child centric and designed to find, assess, and treat developmental concerns early, within the time windows that will yield the optimal outcomes. Our proprietary "whole child" approach to AI fuels our pipeline of diagnostic and therapeutic products for autism, speech and language, ADHD, childhood anxiety, and more. For more information, visit www.cognoa.com.
Company Details
- Employees
- 40
- Founded
- -
- Address
- 2185 Park Blvd, Palo Alto,california 94306,united States
- co****@****noa.com
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- cognoa.com
- Keywords
- Machine Learning, Medtech, Med Device, Diagnostics, Healthtech, AI, Behavioral Health, Early Childhood Developmental Health, Early Childhood Development, Developmental Health, Mental Health, Digital Health, Digital Diagnostics, Early Intervention, Pediatrics, Pediatric Mental Health, Pediatric Behavioral Health, AI Healthcare, Autism.
- HQ
- Palo Alto, California
Cognoa Questions
Cognoa's website is cognoa.com
Cognoa's LinkedIn profile is https://www.linkedin.com/company/cognoa
Cognoa has
40 employees.
View email and phone details for 40
employees at Cognoa.
Cognoa's industry is
Hospitals and Health Care
Cognoa's top competitors are
Curio Digital Therapeutics Inc.,
Cognito Therapeutics, Inc.,
Digital Therapeutics Alliance,
Movn Health,
Mirwork,
Bend Health,
Linus Health,
Akili,
Gocheck Kids,
Bloom Standard.
Cognoa's support email address is contact@cognoa.com
Cognoa's categories are Hospitals and Health Care
Cognoa's founding year is 2013
